UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its position in Vital Farms, Inc. (NASDAQ:VITL - Free Report) by 19.4% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 88,695 shares of the company's stock after buying an additional 14,432 shares during the quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned 0.20% of Vital Farms worth $3,343,000 at the end of the most recent reporting period.
Other large investors have also recently added to or reduced their stakes in the company. CIBC Private Wealth Group LLC increased its stake in Vital Farms by 152.1% during the 4th quarter. CIBC Private Wealth Group LLC now owns 895 shares of the company's stock worth $35,000 after acquiring an additional 540 shares during the period. US Bancorp DE lifted its position in shares of Vital Farms by 160.3% during the 4th quarter. US Bancorp DE now owns 1,416 shares of the company's stock valued at $53,000 after acquiring an additional 872 shares during the period. Frazier Financial Advisors LLC acquired a new stake in shares of Vital Farms during the 4th quarter worth $59,000. Principal Securities Inc. increased its position in shares of Vital Farms by 29.4% in the fourth quarter. Principal Securities Inc. now owns 1,673 shares of the company's stock worth $63,000 after purchasing an additional 380 shares during the period. Finally, Rothschild Investment LLC increased its position in shares of Vital Farms by 191.2% in the fourth quarter. Rothschild Investment LLC now owns 1,814 shares of the company's stock worth $68,000 after purchasing an additional 1,191 shares during the period. Institutional investors own 98.59% of the company's stock.
Wall Street Analyst Weigh In
VITL has been the subject of several recent analyst reports. Stifel Nicolaus raised shares of Vital Farms from a "hold" rating to a "buy" rating and set a $44.00 price objective for the company in a research report on Friday, February 28th. Telsey Advisory Group reaffirmed an "outperform" rating and set a $52.00 price target on shares of Vital Farms in a report on Monday, May 5th. BMO Capital Markets upgraded shares of Vital Farms to a "strong-buy" rating in a research report on Tuesday, May 6th. Morgan Stanley lowered their price objective on shares of Vital Farms from $40.00 to $39.00 and set an "overweight" rating for the company in a research report on Thursday, April 17th. Finally, DA Davidson cut their target price on Vital Farms from $44.00 to $42.00 and set a "buy" rating for the company in a research note on Friday, March 14th. Eight investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, Vital Farms presently has a consensus rating of "Buy" and a consensus price target of $44.63.
View Our Latest Research Report on VITL
Insider Buying and Selling
In related news, CEO Russell Diez-Canseco sold 45,124 shares of the business's stock in a transaction on Monday, April 14th. The shares were sold at an average price of $33.69, for a total value of $1,520,227.56. Following the sale, the chief executive officer now owns 703,736 shares of the company's stock, valued at $23,708,865.84. The trade was a 6.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, insider Matthew Ohayer sold 4,000 shares of the stock in a transaction on Monday, March 24th. The shares were sold at an average price of $31.39, for a total value of $125,560.00. Following the completion of the sale, the insider now owns 6,966,890 shares of the company's stock, valued at $218,690,677.10. The trade was a 0.06% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 93,124 shares of company stock worth $3,019,308 in the last 90 days. Insiders own 21.30% of the company's stock.
Vital Farms Price Performance
Shares of Vital Farms stock traded up $0.64 during midday trading on Monday, hitting $31.52. 913,336 shares of the company traded hands, compared to its average volume of 1,030,979. The firm's fifty day moving average price is $33.41 and its 200-day moving average price is $35.18. The stock has a market cap of $1.40 billion, a price-to-earnings ratio of 28.14 and a beta of 0.89. Vital Farms, Inc. has a 12 month low of $27.91 and a 12 month high of $48.41. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.81 and a current ratio of 3.24.
Vital Farms (NASDAQ:VITL - Get Free Report) last posted its earnings results on Thursday, May 8th. The company reported $0.37 earnings per share for the quarter, topping analysts' consensus estimates of $0.26 by $0.11. The firm had revenue of $162.19 million for the quarter, compared to analysts' expectations of $164.43 million. Vital Farms had a net margin of 8.68% and a return on equity of 22.29%. The company's revenue was up 9.7% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.43 earnings per share. As a group, sell-side analysts forecast that Vital Farms, Inc. will post 1.11 earnings per share for the current year.
About Vital Farms
(
Free Report)
Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.
Read More

Before you consider Vital Farms, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Vital Farms wasn't on the list.
While Vital Farms currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.